Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXQ7YQ
|
||||
Drug Name |
1-((3-fluorophenyl)(p-tolyl)methylene)thiosemicarbazide
|
||||
Synonyms |
CHEMBL261307
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C15H14FN3S
|
||||
Canonical SMILES |
Cc1ccc(cc1)\\C(=N\\NC(=S)N)\\c2cccc(F)c2
|
||||
InChI |
InChI=1S/C15H14FN3S/c1-10-5-7-11(8-6-10)14(18-19-15(17)20)12-3-2-4-13(16)9-12/h2-9H,1H3,(H3,17,19,20)/b18-14-
|
||||
InChIKey |
PWOGTTWZSMQARN-JXAWBTAJSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin L | Target Info | [1587926] | ||
Cathepsin B | Target Info | [1587926] | |||
Reactome | Endosomal/Vacuolar pathway | ||||
Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
MHC class II antigen presentation | |||||
WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.